These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16501629)

  • 1. The role of noninvasive imaging techniques in the assessment of stem cell therapy after acute myocardial infarction.
    San Román JA; Fernández-Avilés F
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S38-41. PubMed ID: 16501629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow cell transfer in acute myocardial infarction.
    Janssens S; Theunissen K; Boogaerts M; Van de Werf F
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S69-72. PubMed ID: 16501635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of cell therapy for acute myocardial infarction.
    Caplice NM
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S129-32. PubMed ID: 16501619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stem cells after myocardial infarction].
    Schächinger V; Dimmeler S; Zeiher AM
    Herz; 2006 Apr; 31(2):127-36; quiz 142-3. PubMed ID: 16738836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of magnetic resonance imaging in cardiac tissue regeneration trials.
    Fuster V; Sanz J; Viles-Gonzalez JF; Rajagopalan S
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S2-7. PubMed ID: 16501625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult stem cells in the treatment of acute myocardial infarction.
    Sharif F; Bartunek J; Vanderheyden M
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):72-83. PubMed ID: 20506335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of imaging in cardiac stem cell therapy.
    Beeres SL; Bengel FM; Bartunek J; Atsma DE; Hill JM; Vanderheyden M; Penicka M; Schalij MJ; Wijns W; Bax JJ
    J Am Coll Cardiol; 2007 Mar; 49(11):1137-48. PubMed ID: 17367656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac cell therapy: the puzzle is waiting to be solved].
    Canepa M; Coviello D; Chiarella F
    G Ital Cardiol (Rome); 2006 Apr; 7(4):252-65. PubMed ID: 16700408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapy: a new perspective in the treatment of patients with acute myocardial infarction.
    Meyer GP; Wollert KC; Drexler H
    Eur J Med Res; 2006 Oct; 11(10):439-46. PubMed ID: 17107878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
    Drexler H; Meyer GP; Wollert KC
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
    Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
    Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction.
    Bartunek J; Wijns W; Heyndrickx GR; Vanderheyden M
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S52-6. PubMed ID: 16501632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction.
    Min JY; Huang X; Xiang M; Meissner A; Chen Y; Ke Q; Kaplan E; Rana JS; Oettgen P; Morgan JP
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):889-97. PubMed ID: 16580449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell therapy for acute myocardial infarction].
    Lemarchand P
    Transfus Clin Biol; 2009 May; 16(2):146-7. PubMed ID: 19443255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.
    Mathieu M; Bartunek J; El Oumeiri B; Touihri K; Hadad I; Thoma P; Metens T; da Costa AM; Mahmoudabady M; Egrise D; Blocklet D; Mazouz N; Naeije R; Heyndrickx G; McEntee K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):646-53. PubMed ID: 19698851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
    Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model.
    Qi CM; Ma GS; Liu NF; Shen CX; Chen Z; Liu XJ; Hu YP; Zhang XL; Teng GJ; Ju SH; Ma M; Tang YL
    Chin Med J (Engl); 2008 Mar; 121(6):544-50. PubMed ID: 18364144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell therapy for acute myocardial infarction.
    Wollert KC
    Curr Opin Pharmacol; 2008 Apr; 8(2):202-10. PubMed ID: 18243051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.